Volume 2, Issue 3
The SciTech e-Merging News is published quarterly as a Section member benefit. Click here to join the Section. The material published reflects the views of the authors and has not been approved by the Section of Science & Technology Law, the House of Delegates or the Board of Governors of the ABA. © 2010 American Bar Association. All rights reserved.
Greetings, dear readers! Below please find the latest issue of the BioBlurb. As always I encourage attorneys, law students, and industry professionals to submit biotech-related stories of interest to my e-mail address. In this issue, find out about the most recent Leukemia treatment breakthrough, Australia's new genetic info disclosure guidelines, and the latest developments on U.S. healthcare bill!
CONTRIBUTOR CREDITS FOR THIS ISSUE:
BIOTECH BREAKTHROUGHS, NEW RESEARCH DIRECTIONS & APPLICATIONS IN CLINICAL MEDICINE:
"Gene Discovery May Help Guide Breast Cancer Care." Researchers discovered that an abnormality in two genes can make a common class of chemotherapy drugs used to fight breast cancer less effective, according to Reuters (January 24, 2010).
"UW-Madison Team's Collagen Find Could Help Treat Arthritis." Researchers at the University of Wisconsin, Madison, developed artificial collagen that could help heal wounds and treat conditions such as arthritis, according to Wisconsin State Journal (January 18, 2010)
"Leukemia Cell 'Breakthrough' Offers Treatment Hope." Scientists believe they have made an important breakthrough in attempts to treat a form of childhood leukemia, according to BBC News (January 22, 2010).
INTERNATIONAL BIOTECH NEWS:
"AUSTRALIA: New Privacy Guidelines for Health Practitioners on Disclosing Genetic Information." The National Health and Medical Research Council, in cooperation with the Office of the Privacy Commissioner, released new guidelines to assist health practitioners in making decisions about disclosing genetic information to their patients' genetic relatives, according to IBLS (January 17, 2010).
BIOTECH INDUSTRY NEWS:
"Asian Drugmakers Rise on U.S. Health Plan Speculation."Asian drugmaker shares posted the biggest gain as a group in the region on speculation U.S. President Barack Obama's plan to overhaul the health-care system will be derailed after Democrats lost a key Senate seat, according to Bloomberg (January 20, 2010).
LEGISLATIVE, POLICY & REGULATORY DEVELOPMENTS:
"Pelosi: Mass. Election Won't Stop Health Bill." Republican victory in the Massachusetts would not mean the death of health reform, according to The Yew York Times (January 18, 2010).
"Governors Protest Obama's Move on Generic Drugs." Six states are asking President Obama to maintain a provision in the health reform bill that would give 12-year market exclusivity to brand-name biotech drugs, according to The Hill Blog Briefing Room (January 19, 2010).
"Beyond Healthcare's Big Tuesday, Money to be Made." Participants at the 28th J.P. Morgan Healthcare Conference in CA expressed positive views on health care reform, according to The Market Watch Health Matters Blog (January 19, 2010).
BIOTECH & SOCIETY: CURE OR ENHANCEMENT?
"First Regenerative Cell Breast Augmentation Surgery Performed Through Stem Cell Assurance Physician Network." Arthur Handal, MD., F.A.C.S. has performed the first regenerative cell breast augmentation through in Boca Raton, Florida, according to WXVT Local News (January 20, 2010).
"Stem Cellutrition, a Division of Stem Cell Assurance, Inc., is Pleased to Introduce Their Exclusive Regenerative Skincare Brand of Cosmetics." Stem Cellutrition, a pioneering clinical-grade skincare and cosmetics company, has launched its state-of-the-art skincare product line formulated to restore elasticity, radiance and smoothness to aging and damaged skin, according to Red Orbit News (January 25, 2010).
Your e-mail address will only be used within the ABA and its entities. We do not sell or rent e-mail addresses to anyone outside the ABA.
American Bar Association | 321 N Clark | Chicago, IL 60610 | 1-800-285-2221